April 19 (Reuters) - Koninklijke DSM NV DSMN.AS :
* DSM AGREES TERMS TO ACQUIRE POSTBIOTICS PIONEER ADARE
BIOME
* THIS TRANSACTION REPRESENTS AN ESTIMATED 2023 EV/EBITDA
MULTIPLE
OF 18X
* DEAL FOR AN ENTERPRISE VALUE OF EUR 275 MILLION
* DSM ANTICIPATES BEING ABLE TO RAPIDLY EXTEND AVAILABILITY
OF
ADARE BIOME'S LACTÉOL® FOR PEOPLE THROUGH ITS B2C UNIT, I-HEALTH
* TRANSACTION REMAINS SUBJECT TO CONSULTATION OF WORKERS
COUNCIL
AND CUSTOMARY REGULATORY CONDITIONS
Source text for Eikon: ID:nPrewzXBLa
Further company coverage: DSMN.AS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))